Long-term impact of alcohol on the brain
While researchers have found that moderate alcohol consumption in older adults is associated with better cognition and well-being than abstinence, excessive alcohol consumption is associated with widespread and significant brain lesions. The effects can manifest much later—mid-life Alcohol Use Disorder has been found to correlate with increased risk of severe cognitive and memory deficits in later life. Alcohol related brain damage is not only due to the direct toxic effects of alcohol; alcohol withdrawal, nutritional deficiency, electrolyte disturbances, and liver damage are also believed to contribute to alcohol-related brain damage.
Adolescent brain development
Consuming large amounts of alcohol over a period of time can impair normal brain development in humans. Deficits in retrieval of verbal and nonverbal information and in visuospatial functioning were evident in youths with histories of heavy drinking during early and middle adolescence.
During adolescence critical stages of neurodevelopment occur, including remodeling and functional changes in synaptic plasticity and neuronal connectivity in different brain regions. These changes may make adolescents especially susceptible to the harmful effects of alcohol. Compared to adults, adolescents exposed to alcohol are more likely to exhibit cognitive deficits (including learning and memory dysfunction). Some of these cognitive effects, such as learning impairments, may persist into adulthood.
Mechanisms of action
Ethanol can trigger the activation of astroglial cells which can produce a proinflammatory response in the brain. Ethanol interacts with the TLR4 and IL-1RI receptors on these cells to activate intracellular signal transduction pathways. Specifically, ethanol induces the phosphorylation of IL-1R-associated kinase (IRAK), ERK1/2, stress-activated protein kinase (SAPK)/JNK, and p38 mitogen-activated protein kinase (p38 MAPK). Activation of the IRAK/MAPK pathway leads to the stimulation of the transcription factors NF-kappaB and AP-1. These transcription factors cause the upregulation of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) expression. The upregulation of these inflammatory mediators by ethanol is also associated with an increase in caspase 3 activity and a corresponding increase in cell apoptosis. The exact mechanism by which various concentrations of ethanol either activates or inhibits TLR4/IL-1RI signaling is not currently known, though it may involve alterations in lipid raft clustering  or cell adhesion complexes and actin cytoskeleton organization.
Changes in dopaminergic and glutamatergic signaling pathways
Intermittent ethanol treatment causes a decrease in expression of the dopamine receptor type 2 (D2R) and a decrease in phosphorylation of 2B subunit of the NMDA receptor (NMDAR2B) in the prefrontal cortex, hippocampus, nucleus accumbens, and for only D2R the striatum. It also causes changes in the acetylation of histones H3 and H4 in the prefrontal cortex, nucleus accumbens, and striatum, suggesting chromatin remodeling changes which may mediate long-term alterations. Additionally, adolescent rats pre-exposed to ethanol have higher basal levels of dopamine in the nucleus accumbens, along with a prolonged dopamine response in this area in response to a challenge dose of ethanol. Together, these results suggest that alcohol exposure during adolescence can sensitize the mesolimbic and mesocortical dopamine pathways to cause changes in dopaminergic and glutamatergic signaling, which may affect the remodeling and functions of the adolescent brain. These changes are significant as alcohol’s effect on NMDARs could contribute to learning and memory dysfunction (see Effects of alcohol on memory).
Inhibition of hippocampal neurogenesis
Excessive alcohol intake (binge drinking) causes a decrease in hippocampal neurogenesis, via decreases in neural stem cell proliferation and newborn cell survival. Alcohol decreases the number of cells in S-phase of the cell cycle, and may arrest cells in the G1 phase, thus inhibiting their proliferation. Ethanol has different effects on different types of actively dividing hippocampal progenitors during their initial phases of neuronal development. Chronic alcohol exposure decreases the number of proliferating cells that are radial glia-like, preneuronal, and intermediate types, while not affecting early neuronal type cells; suggesting ethanol treatment alters the precursor cell pool. Furthermore, there is a greater decrease in differentiation and immature neurons than there is in proliferating progenitors, suggesting that the abnormal decrease in the percentage of actively dividing preneuronal progenitors results in a greater reduction in the maturation and survival of postmitotic cells.
Additionally, alcohol exposure increased several markers of cell death. In these studies neural degeneration seems to be mediated by non-apoptotic pathways. One of the proposed mechanisms for alcohol’s neurotoxicity is the production of nitric oxide (NO), yet other studies have found alcohol-induced NO production to lead to apoptosis (see Neuroinflammation section).
Transient versus stable alterations
Many negative physiologic consequences of alcoholism are reversible during abstinence. As an example, long-term chronic alcoholics suffer a variety of cognitive deficiencies. However, multiyear abstinence resolves most neurocognitive deficits, except for some lingering deficits in spatial processing. Nevertheless there are some frequent long-term consequences that are not reversible during abstinence. Alcohol craving (compulsive need to consume alcohol) is frequently present long-term among alcoholics. Among 461 individuals who sought help for alcohol problems, followup was provided for up to 16 years. By 16 years, 54% of those who tried to remain abstinent without professional help had relapsed, and 39% of those who tried to remain abstinent with help had relapsed.
Long-term, stable consequences of chronic alcohol abuse are thought to be due to stable alterations of gene expression resulting from epigenetic changes within particular regions of the brain. For example, in rats exposed to alcohol for up to 5 days, there was an increase in histone 3 lysine 9 acetylation in the pronociceptin promoter in the brain amygdala complex. This acetylation is an activating mark for pronociceptin. The nociceptin/nociceptin opioid receptor system is involved in the reinforcing or conditioning effects of alcohol.
- Lang, I.; Wallace, R. B.; Huppert, F. A.; Melzer, D. (2007). "Moderate alcohol consumption in older adults is associated with better cognition and well-being than abstinence". Age and Ageing. 36 (3): 256–61. doi:10.1093/ageing/afm001. PMID 17353234.
- Caroline Cassels (July 30, 2014). "Midlife Alcohol Abuse Linked to Severe Memory Impairment". Medscape. WebMD LLC.
- Kuźma, E. B.; Llewellyn, D. J.; Langa, K. M.; Wallace, R. B.; Lang, I. A. (2014). "History of Alcohol Use Disorders and Risk of Severe Cognitive Impairment: A 19-Year Prospective Cohort Study". The American Journal of Geriatric Psychiatry. 22 (10): 1047–1054. doi:10.1016/j.jagp.2014.06.001.
- Neiman, J. (Oct 1998). "Alcohol as a risk factor for brain damage: neurologic aspects". Alcohol Clin Exp Res. 22 (7 Suppl): 346S–351S. doi:10.1111/j.1530-0277.1998.tb04389.x. PMID 9799959.
- Tapert SF, Brown GG, Kindermann SS, Cheung EH, Frank LR, Brown SA (February 2001). "fMRI measurement of brain dysfunction in alcohol-dependent young women". Alcohol. Clin. Exp. Res. 25 (2): 236–45. doi:10.1111/j.1530-0277.2001.tb02204.x. PMID 11236838.
- Squeglia LM, Jacobus J, Tapert SF (January 2009). "The influence of substance use on adolescent brain development". Clin EEG Neurosci. 40 (1): 31–8. doi:10.1177/155005940904000110. PMC . PMID 19278130.
- Brown SA, Tapert SF, Granholm E, Delis DC (February 2000). "Neurocognitive functioning of adolescents: effects of protracted alcohol use". Alcohol Clin Exp Res. 24 (2): 164–71. doi:10.1111/j.1530-0277.2000.tb04586.x. PMID 10698367.
- Guerri, C.; Pascual, M. A. (2010). "Mechanisms involved in the neurotoxic, cognitive, and neurobehavioral effects of alcohol consumption during adolescence". Alcohol. 44 (1): 15–26. doi:10.1016/j.alcohol.2009.10.003. PMID 20113871.
- Blanco Am, V. S. S.; Vallés, S. L.; Pascual, M.; Guerri, C. (2005). "Involvement of TLR4/type I IL-1 receptor signaling in the induction of inflammatory mediators and cell death induced by ethanol in cultured astrocytes". Journal of Immunology. 175 (10): 6893–6899. doi:10.4049/jimmunol.175.10.6893. PMID 16272348.
- Pascual, M.; Blanco, A. M.; Cauli, O.; Miñarro, J.; Guerri, C. (2007). "Intermittent ethanol exposure induces inflammatory brain damage and causes long-term behavioural alterations in adolescent rats". European Journal of Neuroscience. 25 (2): 541–550. doi:10.1111/j.1460-9568.2006.05298.x. PMID 17284196.
- Fernandez-Lizarbe, S.; Pascual, M.; Gascon, M. S.; Blanco, A.; Guerri, C. (2008). "Lipid rafts regulate ethanol-induced activation of TLR4 signaling in murine macrophages". Molecular Immunology. 45 (7): 2007–2016. doi:10.1016/j.molimm.2007.10.025. PMID 18061674.
- Guasch, R. M.; Tomas, M.; Miñambres, R.; Valles, S.; Renau-Piqueras, J.; Guerri, C. (2003). "RhoA and lysophosphatidic acid are involved in the actin cytoskeleton reorganization of astrocytes exposed to ethanol". Journal of Neuroscience Research. 72 (4): 487–502. doi:10.1002/jnr.10594. PMID 12704810.
- Pascual, M.; Boix, J.; Felipo, V.; Guerri, C. (2009). "Repeated alcohol administration during adolescence causes changes in the mesolimbic dopaminergic and glutamatergic systems and promotes alcohol intake in the adult rat". Journal of Neurochemistry. 108 (4): 920–931. doi:10.1111/j.1471-4159.2008.05835.x. PMID 19077056.
- Morris, S. A.; Eaves, D. W.; Smith, A. R.; Nixon, K. (2009). "Alcohol inhibition of neurogenesis: A mechanism of hippocampal neurodegeneration in an adolescent alcohol abuse model". Hippocampus. 20 (5): 596–607. doi:10.1002/hipo.20665. PMC . PMID 19554644.
- Taffe, M. A.; Kotzebue, R. W.; Crean, R. D.; Crawford, E. F.; Edwards, S.; Mandyam, C. D. (2010). "Long-lasting reduction in hippocampal neurogenesis by alcohol consumption in adolescent nonhuman primates". Proceedings of the National Academy of Sciences. 107 (24): 11104–11109. doi:10.1073/pnas.0912810107. PMC . PMID 20534463.
- Oscar-Berman M, Valmas MM, Sawyer KS, Ruiz SM, Luhar RB, Gravitz ZR (2014). "Profiles of impaired, spared, and recovered neuropsychologic processes in alcoholism". Handb Clin Neurol. 125: 183–210. doi:10.1016/B978-0-444-62619-6.00012-4. PMC . PMID 25307576.
- Fein G, Torres J, Price LJ, Di Sclafani V (September 2006). "Cognitive performance in long-term abstinent alcoholic individuals". Alcohol. Clin. Exp. Res. 30 (9): 1538–44. doi:10.1111/j.1530-0277.2006.00185.x. PMC . PMID 16930216.
- Bottlender M, Soyka M (2004). "Impact of craving on alcohol relapse during, and 12 months following, outpatient treatment". Alcohol Alcohol. 39 (4): 357–61. doi:10.1093/alcalc/agh073. PMID 15208171.
- Moos RH, Moos BS (February 2006). "Rates and predictors of relapse after natural and treated remission from alcohol use disorders". Addiction. 101 (2): 212–22. doi:10.1111/j.1360-0443.2006.01310.x. PMC . PMID 16445550.
- Krishnan HR, Sakharkar AJ, Teppen TL, Berkel TD, Pandey SC (2014). "The epigenetic landscape of alcoholism". Int. Rev. Neurobiol. 115: 75–116. doi:10.1016/B978-0-12-801311-3.00003-2. PMC . PMID 25131543.
- Jangra A, Sriram CS, Pandey S, Choubey P, Rajput P, Saroha B, Bezbaruah BK, Lahkar M (October 2016). "Epigenetic Modifications, Alcoholic Brain and Potential Drug Targets". Ann Neurosci. 23 (4): 246–260. doi:10.1159/000449486. PMC . PMID 27780992.
- Berkel TD, Pandey SC (April 2017). "Emerging Role of Epigenetic Mechanisms in Alcohol Addiction". Alcohol. Clin. Exp. Res. 41 (4): 666–680. doi:10.1111/acer.13338. PMC . PMID 28111764.
- D'Addario C, Caputi FF, Ekström TJ, Di Benedetto M, Maccarrone M, Romualdi P, Candeletti S (February 2013). "Ethanol induces epigenetic modulation of prodynorphin and pronociceptin gene expression in the rat amygdala complex". J. Mol. Neurosci. 49 (2): 312–9. doi:10.1007/s12031-012-9829-y. PMID 22684622.